Genetic ‘fingerprint’ may ID breast cancer patients likely to benefit from potentially toxic chemo, study finds

A genetic ‘fingerprint’ may ID breast cancer patients likely to benefit from potentially toxic chemo, a Standford Medicine study finds. Conversely, these drugs could be avoided if it was known a patient was unlikely to benefit from their use. If you would like to read more about this study, click the link below: http://med.stanford.edu/news/all-news/2019/11/genetic-_fingerprint-may-id-breast-cancer-patients-likely-to-ben.html?fbclid=IwAR2WwjX6SzgZCBkIdO999FPMBM92bUuHyBbMhwWf5nySznZTw4DNqCUusK4